Daiichi Sankyo Acquires Plexxikon for $935,000,000

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9d3a1345-38bc-4304-af0f-3b7fce475788&Preview=1
Date
2/28/2011
Company Name
Plexxikon
Mailing Address
91 Bolivar Drive Berkeley, CA 94710
Company Description
Plexxikon is a leader in the discovery and development of novel, small molecule pharmaceuticals. The company has utilized its proprietary discovery platform to successfully develop a portfolio of clinical and preclinical stage programs in a number of therapeutic areas, including metabolic disease, oncology, inflammation, CNS and cardiovascular disease.
Website
http://www.plexxikon.com
Transaction Type
M&A
Transaction Amount
$935,000,000
Transaction Round
Proceeds Purposes
M&A Terms
The purchase price for Plexxikon is $805 million up-front. Near-term milestone payments associated with the approval of PLX4032 could total an additional $130 million.